Elevance Health (ELV) Q3 2024 Earnings
Elevance Health reported Q3 2024 revenue of $45.1B, beat analyst consensus of $43.5B by $1.7B. Diluted EPS came in at $8.37, missed the $9.66 consensus by $1.29. Elevance Health reports across 3 business segments, led by Health Benefits, CarelonRx, and Carelon Services.
Financial Snapshot
Trailing eight quarters through Q3 2024
Q3 2024 Earnings FAQ
Common questions about Elevance Health's Q3 2024 earnings report.
Elevance Health (ELV) reported Q3 2024 earnings on October 17, 2024 before market open.
Elevance Health reported revenue of $45.1B and diluted EPS of $8.37 for Q3 2024.
Revenue beat the consensus estimate of $43.5B by $1.7B. EPS missed the consensus estimate of $9.66 by $1.29.
You can read the 10-Q periodic report (0001156039-24-000122) directly on SEC EDGAR. The filing index links above go to sec.gov.